Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Astex Therapeutics Ltd.

Headquarters: Cambridge, United Kingdom
Website: N/A
Year Founded: 1999
Status: Acquired

BioCentury | Dec 14, 2015
Product Development

Following CoMMpass

How a patient-run study is influencing R&D and treatment in myeloma
BioCentury | Sep 9, 2013
Finance

E round in the hand vs. IPO in the bush

Argos opts for private funds on offer; passes on retesting IPO waters
BioCentury | Sep 2, 2013
Clinical News

SGI-110: Phase I/II data

BioCentury | Jul 1, 2013
Clinical News

SGI-110: Interim Phase I/II data

BioCentury | Dec 3, 2012
Clinical News

PLX cells regulatory update

BioCentury | Apr 23, 2012
Clinical News

SGI-110: Interim Phase I/II data

BioCentury | Apr 5, 2012
Distillery Therapeutics

Indication: Cancer

BioCentury | Feb 13, 2012
Clinical News

Dacogen decitabine regulatory update

BioCentury | Jan 23, 2012
Company News

Astex Pharmaceuticals, GlaxoSmithKline deal

Items per page:
1 - 10 of 65
Help Center
Username
Request a Demo
Request Training
Ask a Question